Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 7Sarcoma 2Genitourinary 2Thoracic 1NET 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Sarcoma 523Glioblastoma 179Gliosarcoma 178Osteosarcoma 155Dendritic Cell Sarcoma, Interdigitating 114Brain Neoplasms 113Gastrointestinal Stromal Tumors 108Central Nervous System Neoplasms 102Rhabdomyosarcoma 81Lymphoma 79Glioma 79Burkitt Lymphoma 79Lymphoma, Non-Hodgkin 78Recurrence 76Leiomyosarcoma 75Precursor Cell Lymphoblastic Leukemia-Lymphoma 73Lymphoma, Large B-Cell, Diffuse 70Liposarcoma 69Astrocytoma 68Sarcoma, Ewing 67Lymphoma, Follicular 63Neuroblastoma 60Lymphoma, Mantle-Cell 58Leukemia, Lymphocytic, Chronic, B-Cell 57Lymphoma, B-Cell, Marginal Zone 56Lymphoma, Large-Cell, Immunoblastic 54Hodgkin Disease 54Leukemia, Myeloid, Acute 53Neuroectodermal Tumors, Primitive, Peripheral 52Neoplasm Metastasis 51

Interventions

Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Adenocarcinoma, Clear Cell × Sarcoma × Clear all
NCT05500391 2026-03-18

SUR-CAN

Centre Oscar Lambret

Phase 2 Recruiting
88 enrolled
CNSEndocrineGastrointestinalNETSarcoma

Carcinosarcoma, Glioma, Seminoma, Adenocarcinoma, Clear Cell, Carcinoma, Small Cell, Sex Cord-Gonadal Stromal Tumors, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

NCT03241745 2024-12-27

A Study of Nivolumab in Selected Uterine Cancer Patients

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
35 enrolled 8 charts
GynecologicSarcoma

Carcinosarcoma, Leiomyosarcoma, Uterine Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡